Clinical study on hemoporfin PDT for infant facial port-wine stains

Photodiagnosis Photodyn Ther. 2019 Mar:25:106-110. doi: 10.1016/j.pdpdt.2018.09.012. Epub 2018 Nov 19.

Abstract

Objective: To observe the clinical efficacy and therapeutic response of Hemoporfin photodynamic therapy (PDT) for infant facial port-wine stains (PWS).

Method: Hemoporfin PDT was used to treat 100 cases of infant facial PWS. After receiving Hemoporfin skin test, the cases with a negative skin test result were intravenously injected with Hemippofen (5 mg/kg) and irradiated under 532 nm LED green light. After treatment, a follow-up visit was paid through WeChat and Dermlink PWS consulting platform, in order to observe the therapeutic response and clinical efficacy.

Result: The follow-up visit showed an effective rate of 98%, including 85 cases of itching (85%), 100 cases of edema (100%), 89 cases of purpura-like change (89%), 33 cases of crust (33%), 2 cases of hyperpigmentation (2%) and 2 cases of scars (2%), with no allergy and other systematic adverse reaction.

Conclusion: Hemoporfin PDT has a high clinical efficacy and response rate in treating infant facial PWS, with slight adverse reactions.

Keywords: Hemoporfin; Infant; PDT; PWS; Port wine stains.

MeSH terms

  • Child, Preschool
  • Face
  • Female
  • Hematoporphyrins / adverse effects
  • Hematoporphyrins / therapeutic use*
  • Humans
  • Infant
  • Male
  • Photochemotherapy / adverse effects
  • Photochemotherapy / methods*
  • Photosensitizing Agents / adverse effects
  • Photosensitizing Agents / therapeutic use*
  • Port-Wine Stain / drug therapy*

Substances

  • Hematoporphyrins
  • Photosensitizing Agents
  • hematoporphyrin monomethyl ether